IMA Clinical Research

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Depression3 trials
• Schizophrenia1 trial

Phase

• Phase 26 trials
• Phase 31 trial

Status

• Completed7 trials

Lead sponsor

• Biohaven Therapeutics Ltd.2 trials
• Engrail Therapeutics INC2 trials
• Indivior Inc.1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• Sirtsei Pharmaceuticals, Inc.1 trial

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder

  NCT07193563· Phase 2· Engrail Therapeutics INC· Source

• Completed

  Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

  NCT06423781· Phase 2· Biohaven Therapeutics Ltd.· Source

• Completed

  Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

  NCT06384157· Phase 2· Indivior Inc.· Source

• Completed

  Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

  NCT06419608· Phase 2· Biohaven Therapeutics Ltd.· Source

• Completed

  A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

  NCT06254612· Phase 2· Sirtsei Pharmaceuticals, Inc.· Source

• Completed

  ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

  NCT05749055· Phase 2· Engrail Therapeutics INC· Source

• Completed

  A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

  NCT05628103· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source